12 Health Care Stocks Moving In Tuesday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Tuesday's after-market session, several healthcare stocks experienced significant movements. Theseus Pharmaceuticals (THRX) saw a 34.1% increase, while PaxMedica (PXMD) rose by 19.87%. 180 Life Sciences (ATNF) went up by 17.94% following their Q3 earnings release 3 days prior. Exagen (XGN) and Renalytix (RNLX) also saw gains after their recent earnings reports. Spero Therapeutics (SPRO) increased by 8.1% post Q3 earnings. Conversely, Harrow (HROW) dropped by 22.1%, Tenax Therapeutics (TENX) by 15.89%, Beyond Air (XAIR) by 13.8%, Owlet (OWLT) by 12.55%, TRACON Pharma (TCON) by 10.15%, and Inspire Veterinary (IVP) by 9.8% after their earnings reports.
November 14, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
180 Life Sciences stock rose by 17.94% to $0.55, with trading volume at 1128.4% of its 100-day average following Q3 earnings released 3 days ago. The market cap is $3.2 million.
The surge in ATNF's stock price post-Q3 earnings and the exceptionally high trading volume indicate a strong market reaction to the earnings report, suggesting potential growth or positive news.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 95
POSITIVE IMPACT
PaxMedica stock increased by 19.87% to $2.05, with trading volume at 17.2% of its 100-day average. The company's market cap is $2.0 million.
The substantial increase in PXMD's stock price could be driven by investor reactions to recent company news or market conditions. The low market cap suggests higher volatility and potential for rapid price changes.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Renalytix shares rose by 9.41% to $0.93 following the Q1 earnings report. The market cap is $45.3 million.
The increase in RNLX's stock price after the Q1 earnings report indicates that the financial results may have been positive or better than expected, leading to investor optimism.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 85
POSITIVE IMPACT
Spero Therapeutics stock went up by 8.1% to $1.2, with the market cap at $63.2 million after the Q3 earnings report.
Spero Therapeutics' stock price increase post-Q3 earnings suggests that the earnings report was received positively by the market, potentially indicating good financial health or prospects.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 85
POSITIVE IMPACT
Theseus Pharmaceuticals stock rose by 34.1% to $2.87 in after-market trading, with volume at 116.8% of its 100-day average. The company's market cap is $125.1 million.
The significant after-market gain for THRX could indicate positive investor sentiment, potentially due to recent company developments or in anticipation of upcoming earnings. High trading volume suggests strong investor interest.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Exagen shares increased by 9.58% to $1.6 after the Q3 earnings report. The company's market cap is $26.9 million.
Exagen's stock price appreciation following the Q3 earnings report suggests that the earnings may have met or exceeded market expectations, leading to positive investor sentiment.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 85